Inovio Pharmaceuticals In...

NASDAQ: INO · Real-Time Price · USD
1.97
0.35 (21.60%)
At close: Aug 15, 2025, 12:38 PM

Inovio Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
217.76K 832.01K 10.26M 1.77M
Cost of Revenue
3.13M 3.5M 5.5M 4.73M
Gross Profit
-2.91M -2.67M 4.77M -2.96M
Operating Income
-112.4M -143.94M -267.57M -301.22M
Interest Income
4.77M 8.13M 4.78M 3.36M
Pretax Income
-107.25B -135.12M -277.65M -303.22M
Net Income
-107.25M -135.12M -279.82M -303.66M
Selling & General & Admin
37B 47.58M 90.19M 53.75M
Research & Development
75.62B 86.68M 187.65M 249.24M
Other Expenses
n/a -1.7M n/a n/a
Operating Expenses
112.62B 132.56M 277.84M 302.99M
Interest Expense
177.83K 1.22M 1.25M 1.94M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
112.62M 136.06M 284.54M 302.99M
Income Tax Expense
-107.15B n/a 2.17M 434.39K
Shares Outstanding (Basic)
27.16M 22.17M 19.89M 214.62M
Shares Outstanding (Diluted)
27.16M 22.17M 19.89M 214.62M
EPS (Basic)
-3.95 -6.09 -14.07 -1.42
EPS (Diluted)
-3.95 -6.09 -14.07 -1.42
EBITDA
-103.95M -130.39M -270.9M -296.56M
EBIT
-107.08M -133.89M -276.4M -301.29M
Depreciation & Amortization
3.13M 3.5M 5.5M 4.73M